| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/06/1996 | WO1996016977A1 Novel anti-hiv agent |
| 06/06/1996 | WO1996016976A1 Antisense oligonucleotide and carcinostatic agent containing the same |
| 06/06/1996 | WO1996016974A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | WO1996016676A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | WO1996016673A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | WO1996016668A1 Novel hedgehog-derived polypeptides |
| 06/06/1996 | WO1996016665A1 Cd40 associated proteins |
| 06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/06/1996 | WO1995032298A3 Safe vectors for gene therapy |
| 06/06/1996 | CA2207869A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | CA2206574A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 06/06/1996 | CA2206553A1 Receptor for cell-binding domain of thrombospondins |
| 06/06/1996 | CA2206534A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | CA2206526A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | CA2206441A1 Cd40 associated proteins |
| 06/06/1996 | CA2206305A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 06/06/1996 | CA2206205A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | CA2206113A1 Expressed chemokines, their production and uses |
| 06/06/1996 | CA2205849A1 Transgenic plants with improved biomass production |
| 06/06/1996 | CA2205563A1 Terminal repeat amplification method |
| 06/06/1996 | CA2204920A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids for coding for the same and use thereof in diagnostic and prophylactic methods and kits |
| 06/05/1996 | EP0714988A2 Method for quantifying nucleic acids |
| 06/05/1996 | EP0714987A2 Method for quantifying genomic DNA |
| 06/05/1996 | EP0714986A1 Method of detecting specific nucleic acid sequences |
| 06/05/1996 | EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity |
| 06/05/1996 | EP0714981A2 PRLTS proteins and DNA's encoding the same |
| 06/05/1996 | EP0714980A1 Hypermutagenesis |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/05/1996 | EP0714910A1 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements |
| 06/05/1996 | EP0714711A1 Improved fume hood having a trimodal piston driven sash and a travel interference system for said sash |
| 06/05/1996 | EP0714665A2 Osteogenic devices |
| 06/05/1996 | EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus |
| 06/05/1996 | EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/05/1996 | EP0714449A1 Oligonucleotide modulation of protein kinase c |
| 06/05/1996 | EP0714446A1 Chitinase, dna coding therefor and plants containing same |
| 06/05/1996 | EP0714445A1 Glucoamylase promoter obtained from neurospora crassa and its use in the production of heterologous polypeptides |
| 06/05/1996 | EP0714444A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 06/05/1996 | EP0714443A1 Detection and prevention of mycoplasma hominis infection |
| 06/05/1996 | EP0714442A1 Recombinant alternaria alternata allergenes |
| 06/05/1996 | EP0714441A1 Recombinant cladosporium herbarum allergens |
| 06/05/1996 | EP0714440A1 T cell epitopes of ryegrass pollen allergen |
| 06/05/1996 | EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody |
| 06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 06/05/1996 | EP0714437A1 Dna encoding inward rectifier, g-protein activated, mammalian, potassium kga channel and uses thereof |
| 06/05/1996 | EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus |
| 06/05/1996 | EP0714435A1 Pro-urokinase mutants |
| 06/05/1996 | EP0714409A1 Antibodies |
| 06/05/1996 | EP0714408A1 Tryptase inhibitor |
| 06/05/1996 | EP0714406A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 06/05/1996 | EP0714403A1 Aqueous multiple-phase isolation of polypeptide |
| 06/05/1996 | EP0714401A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8 |
| 06/05/1996 | EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 06/05/1996 | EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/05/1996 | EP0714237A1 Method of increasing the yield of herbicide-resistant crop plants |
| 06/05/1996 | EP0550509B1 Process for the production of purified glycolipids by the diaphragm separation method |
| 06/05/1996 | EP0465560B1 VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS |
| 06/05/1996 | EP0312542B1 Gamma, delta t cell receptor and methods for detection |
| 06/05/1996 | DE4442970A1 Model for screening cpds. for inhibition of Helicobacter |
| 06/05/1996 | CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy |
| 06/05/1996 | CN1124039A Lipase variants |
| 06/04/1996 | US5523520 Mutant dwarfism gene of petunia |
| 06/04/1996 | US5523393 BCL-2 proteins |
| 06/04/1996 | US5523392 Purification of DNA on aluminum silicates, and phosphosilicates |
| 06/04/1996 | US5523391 For treating leukemia, uterine cancer |
| 06/04/1996 | US5523389 Inhibitors of human immunodeficiency virus |
| 06/04/1996 | US5523290 Antiproliferation factor |
| 06/04/1996 | US5523287 Thrombin-inhibitory protein from assassin bugs |
| 06/04/1996 | US5523231 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 06/04/1996 | US5523226 Obtaining embryonic stem cell for forming chimeric swine by introducing cultured swine embryonic stem cell into immunodeficient mouse, using cell from culture capable of producing tumor |
| 06/04/1996 | US5523225 DNA sequence encoding human cystathionine β-synthase |
| 06/04/1996 | US5523224 Recombinant D-hydantoinase, a process for the production and use |
| 06/04/1996 | US5523222 Polyelectrolyte DNA conjugation and genetic transformation of an animal |
| 06/04/1996 | US5523221 Method for the directional cloning of DNA |
| 06/04/1996 | US5523215 Culturing host cell expressing desired protein in medium containing copper ions, disrupting, incubating insoluble fraction with chaotropic agent to dissolve contaminants, separating, treating insoluble fraction with reducing agent |
| 06/04/1996 | US5523209 Culturing a cell expressing a chimeric integrin and contacting with ligand that binds to reporter integrin only when activated |
| 06/04/1996 | US5523204 Detection of nucleic acids in cells by strand displacement amplification |
| 06/04/1996 | US5523089 Borrelia antigen |
| 06/04/1996 | US5523085 Monoclonal antibody in destruction of small cell lung carcinoma |
| 06/04/1996 | CA2059541C Method of preparing a plasmid having both the ability to express a retroviral gene and the ability to process expression products after translation, the resultant plasmid and expression products thereof |
| 06/04/1996 | CA2054551C Monoclonal antibodies to mite allergen and the use thereof |
| 06/04/1996 | CA1338366C Efficient prokaryotic expression system |
| 05/31/1996 | CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties |
| 05/30/1996 | WO1996016187A1 Lyophilized bioluminescent bacterial reagent for the detection of toxicants |
| 05/30/1996 | WO1996016184A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 05/30/1996 | WO1996016183A1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy |
| 05/30/1996 | WO1996016182A2 Microspore-specific regulatory element |
| 05/30/1996 | WO1996016181A1 Expression plasmids for yeasts |
| 05/30/1996 | WO1996016180A1 Production of variant nisin |
| 05/30/1996 | WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 05/30/1996 | WO1996016178A1 Immunogens for stimulating mucosal immunity |
| 05/30/1996 | WO1996016177A1 A process for producing polypeptides with reduced allergenicity |
| 05/30/1996 | WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
| 05/30/1996 | WO1996016175A2 Lgmd gene coding for a calcium dependent protease |
| 05/30/1996 | WO1996016174A2 Cephalosporin c amidohydrolase, production and use |
| 05/30/1996 | WO1996016173A2 Modified proteinase inhibitors |
| 05/30/1996 | WO1996016172A2 Modulators of anchoring protein function |
| 05/30/1996 | WO1996016171A1 Toxins from the wasp bracon hebetor |
| 05/30/1996 | WO1996016170A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |